Clearmind Medicine Inc. (CMND) Form 10-Q Quarterly Reports
Clearmind Medicine Inc. (CMND) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CMND
CIK: 1892500
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 10/31
State: Z4
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Brightman Almagor Zohar & Co.
Auditor SinceSince 10/31/2022 12:00:00 AM
Lead Engagement PartnerDan Lewkowicz
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-16 | 2026-10-16 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-110220 | View SEC Doc Filr Page |
| 6-K | 2026-10-13 | 2026-10-13 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-108644 | View SEC Doc Filr Page |
| 6-K | 2026-10-08 | 2026-10-08 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-107727 | View SEC Doc Filr Page |
| 6-K | 2026-10-07 | 2026-10-07 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-107425 | View SEC Doc Filr Page |
| 6-K | 2026-09-30 | 2026-09-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-105269 | View SEC Doc Filr Page |
| 6-K | 2026-09-23 | 2026-09-23 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-102371 | View SEC Doc Filr Page |
| 6-K | 2026-09-17 | 2026-09-17 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-100943 | View SEC Doc Filr Page |
| 6-K | 2026-09-14 | 2026-09-14 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-099433 | View SEC Doc Filr Page |
| 6-K | 2026-09-10 | 2026-07-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-098779 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-09-08 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-097845 | View SEC Doc Filr Page |
| 6-K | 2026-09-04 | 2026-09-04 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-097410 | View SEC Doc Filr Page |
| 6-K | 2026-09-02 | 2026-09-02 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-096692 | View SEC Doc Filr Page |
| 6-K | 2026-09-01 | 2026-09-01 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-095981 | View SEC Doc Filr Page |
| 6-K | 2026-08-24 | 2026-08-24 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-093015 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000930413-26-002480 | View SEC Doc Filr Page |
| 6-K | 2026-08-11 | 2026-08-11 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-087761 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-08-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-086120 | View SEC Doc Filr Page |
| 6-K | 2026-08-03 | 2026-08-03 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-084263 | View SEC Doc Filr Page |
| 6-K | 2026-07-30 | 2026-07-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-083320 | View SEC Doc Filr Page |
| 6-K | 2026-07-20 | 2026-07-20 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-079596 | View SEC Doc Filr Page |
| 6-K | 2026-07-17 | 2026-07-17 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-079147 | View SEC Doc Filr Page |
| 6-K | 2026-07-16 | 2026-07-16 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-078630 | View SEC Doc Filr Page |
| 6-K | 2026-07-13 | 2026-07-13 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-077542 | View SEC Doc Filr Page |
| 6-K | 2026-07-10 | 2026-07-10 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-077122 | View SEC Doc Filr Page |
| 6-K | 2026-07-07 | 2026-07-07 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-075933 | View SEC Doc Filr Page |